Speaker: Professor Regine Süss, Professor of Pharmaceutical Technology, Albert-Ludwigs-University of Freiburg, Germany
Title: The challenge of targeted nanoparticulate drug delivery in gene therapy and for tumour treatment
Chair: Dr Kati Richter, NHMRC Early Career Researcher, Discipline of Surgery, The University of Adelaide, Level 2, BHI TQEH.
Speaker biography: Regine Süss studied Pharmacy & Pharmaceutical Sciences at the University of Mainz, Germany, in collaboration with a pharmaceutical company. She undertook a pharmaceutical internship in Buffalo, NY and worked as a research fellow at the University of California in San Francisco.
Since 2007 Regine has been the Professor of Pharmaceutical Technology and Biopharmacy at the Albert-Ludwigs-University of Freiburg, Germany. Her research focus is on the development of drug carriers in the nanoscale, in particular for targeted tumour therapy and gene therapy.
Regine is collaborating with Dr Kati Richter, an external supervisor of PhD student Laurine Kaul (who is undertaking a joint PhD program between The University of Adelaide and Albert-Ludwigs University in Freiburg).